Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: Insights from SAFEHEART registry-Reference-Cited by-同舟云学术

Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: Insights from SAFEHEART registry

Published:2016-07 Issue:4 Volume:10 Page:953-961
ISSN:1933-2874
Container-title:Journal of Clinical Lipidology
language:en
Short-container-title:Journal of Clinical Lipidology

Author:

Alonso Rodrigo,Díaz-Díaz Jose Luis,Arrieta Francisco,Fuentes-Jiménez Francisco,de Andrés Raimundo,Saenz Pedro,Ariceta Gema,Vidal-Pardo José I.,Almagro Fatima,Argueso Rosa,Prieto-Matos Pablo,Miramontes José P.,Pintó Xavier,Rodriguez-Urrego Johana,Perez de Isla Leopoldo,Mata Pedro

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference30 articles.

1. Homozygous familial hypercholesterolaemia;Macchiaiolo;Lancet,2012

2. Monogenic hypercholesterolemia: new insights in pathogenesis and treatment;Rader;J Clin Invest,2003

3. The doctor's dilemma: challenges in the diagnosis and care of homozygous familial hypercholesterolemia;Baum;J Clin Lipidol,2014

4. Homozygous familial Hypercholesterolemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on familial Hypercholesterolemia of the European Atherosclerosis Society;Cuchel;Eur Heart J,2014

5. Homozygous autosomal dominant hypercholesterolemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome;Sjouke;Eur Heart J,2015

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacy;European Heart Journal;2024-06-10

2. Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia;JAMA Cardiology;2024-04-01

3. Improved lipid-lowering treatment and reduction in cardiovascular disease burden in homozygous familial hypercholesterolemia: The SAFEHEART follow-up study;Atherosclerosis;2024-03

4. Sex differences in efficacy and safety of PCSK9 monoclonal antibodies: A real-world registry;Atherosclerosis;2023-11

5. Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry;Journal of the American Heart Association;2023-05-02